|1.||Shawkat, Tarek: 1 article (01/2015)|
|2.||Shawkat, Hisham: 1 article (01/2015)|
|3.||Helmy, Sherine: 1 article (01/2015)|
|4.||Yakoot, Mostafa: 1 article (01/2015)|
|5.||Study Group of Pediatric Clinical Investigation of Pertusis, Program for Vaccine Preventable Diseases, Chinese Association of Preventive Medicine: 1 article (10/2010)|
|6.||Dai, Erbin: 1 article (01/2009)|
|7.||Hatton, Mark: 1 article (01/2009)|
|8.||McFadden, Grant: 1 article (01/2009)|
|9.||Macaulay, Colin: 1 article (01/2009)|
|10.||Richardson, Mary: 1 article (01/2009)|
03/01/2008 - "In the present study, we reported a novel tumor vaccine (mimovirus), a viron-size particulate which consisted of a cell-penetrating peptide of Tat(49-57), a CTL epitope peptide survivin(85-93) and a plasmid encoding murine interleukin-15 (IL-15). "
07/01/1981 - "Administration of infectious RadLV systemically into RL12-NP tumor-bearing animals converted these tumors to viron antigen expressors with levels in superinfected tumors equivalent to those found in RL12-Rad-induced tumors. "
01/01/2015 - "Eighty-two consecutive patients presenting to our outpatient clinics as already-known or newly-diagnosed cases of chronic hepatitis C virus (HCV) infection, were entered into the study and randomized to three groups to receive escalating doses of Viron for 6 months. "
09/01/1996 - "Using a herpes simplex virus-1 (HSV-1) vector system we packaged the CaBP gene, parvalbumin, or the marker gene, beta-galactosidase (beta-gal), correctly in viron particles, which were found upon infection to express mRNA specific to these vectors. "
|3.||Chronic Hepatitis C
|5.||Venous Thrombosis (Deep-Vein Thrombosis)
|1.||Interleukin-15 (Interleukin 15)
|3.||Messenger RNA (mRNA)